Lena Gaissmaier, Petros Christopoulos. Respiration 2020
Times Cited: 11
Times Cited: 11
Times Cited
Times Co-cited
Similarity
Breaking Bottlenecks for the TCR Therapy of Cancer.
Lena Gaissmaier, Mariam Elshiaty, Petros Christopoulos. Cells 2020
Lena Gaissmaier, Mariam Elshiaty, Petros Christopoulos. Cells 2020
54
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.
Petros Christopoulos, Marc A Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jens Kollmeier, Volker Baum, Thomas Muley, Philipp A Schnabel, Helge Bischoff,[...]. Lung Cancer 2018
Petros Christopoulos, Marc A Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jens Kollmeier, Volker Baum, Thomas Muley, Philipp A Schnabel, Helge Bischoff,[...]. Lung Cancer 2018
36
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt,[...]. Int J Cancer 2019
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt,[...]. Int J Cancer 2019
36
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. J Clin Oncol 2021
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. J Clin Oncol 2021
36
Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231.
J M Ellis, V Henson, R Slack, J Ng, R J Hartzman, C Katovich Hurley. Hum Immunol 2000
J M Ellis, V Henson, R Slack, J Ng, R J Hartzman, C Katovich Hurley. Hum Immunol 2000
27
TRUCKs: the fourth generation of CARs.
Markus Chmielewski, Hinrich Abken. Expert Opin Biol Ther 2015
Markus Chmielewski, Hinrich Abken. Expert Opin Biol Ther 2015
27
Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL.
Petros Christopoulos, Dietmar Pfeifer, Kilian Bartholomé, Marie Follo, Jens Timmer, Paul Fisch, Hendrik Veelken. Blood 2011
Petros Christopoulos, Dietmar Pfeifer, Kilian Bartholomé, Marie Follo, Jens Timmer, Paul Fisch, Hendrik Veelken. Blood 2011
27
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors.
Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke Winter, Felix J Herth, Thomas Muley, Stephan Liersch, Helge Bischoff,[...]. Cancers (Basel) 2020
Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke Winter, Felix J Herth, Thomas Muley, Stephan Liersch, Helge Bischoff,[...]. Cancers (Basel) 2020
27
Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
18
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein,[...]. Nat Med 2015
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein,[...]. Nat Med 2015
18
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
Amaia Martinez-Usatorre, Santiago J Carmona, Céline Godfroid, Céline Yacoub Maroun, Sara Labiano, Pedro Romero. Front Immunol 2020
Amaia Martinez-Usatorre, Santiago J Carmona, Céline Godfroid, Céline Yacoub Maroun, Sara Labiano, Pedro Romero. Front Immunol 2020
18
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F de Miranda, Cheri P Goodall, Tiffany C Blair, Bernard A Fox, Jason E McDermott,[...]. Nat Commun 2018
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F de Miranda, Cheri P Goodall, Tiffany C Blair, Bernard A Fox, Jason E McDermott,[...]. Nat Commun 2018
18
Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.
Karen M Kaluza, Timothy Kottke, Rosa Maria Diaz, Diana Rommelfanger, Jill Thompson, Richard Vile. Hum Gene Ther 2012
Karen M Kaluza, Timothy Kottke, Rosa Maria Diaz, Diana Rommelfanger, Jill Thompson, Richard Vile. Hum Gene Ther 2012
18
Proteomics. Tissue-based map of the human proteome.
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
18
Chimeric antigen receptor T cell persistence and memory cell formation.
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
18
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, Aaron P Rapoport, Bruce L Levine, Lyndsey Emery, Leslie Litzky, Adam Bagg, Beatriz M Carreno, Patrick J Cimino,[...]. Blood 2013
Gerald P Linette, Edward A Stadtmauer, Marcela V Maus, Aaron P Rapoport, Bruce L Levine, Lyndsey Emery, Leslie Litzky, Adam Bagg, Beatriz M Carreno, Patrick J Cimino,[...]. Blood 2013
18
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.
Maria R Parkhurst, James C Yang, Russell C Langan, Mark E Dudley, Debbie-Ann N Nathan, Steven A Feldman, Jeremy L Davis, Richard A Morgan, Maria J Merino, Richard M Sherry,[...]. Mol Ther 2011
Maria R Parkhurst, James C Yang, Russell C Langan, Mark E Dudley, Debbie-Ann N Nathan, Steven A Feldman, Jeremy L Davis, Richard A Morgan, Maria J Merino, Richard M Sherry,[...]. Mol Ther 2011
18
Reprogramming human T cell function and specificity with non-viral genome targeting.
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P Jonathan Li, Joseph Hiatt, Justin Saco, Paige Krystofinski, Han Li,[...]. Nature 2018
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P Jonathan Li, Joseph Hiatt, Justin Saco, Paige Krystofinski, Han Li,[...]. Nature 2018
18
The peripheral helper T-cell repertoire in untreated indolent B-cell lymphomas: evidence for antigen-driven lymphomagenesis.
P Christopoulos, M Follo, P Fisch, H Veelken. Leukemia 2008
P Christopoulos, M Follo, P Fisch, H Veelken. Leukemia 2008
20
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Laura A Johnson, Richard A Morgan, Mark E Dudley, Lydie Cassard, James C Yang, Marybeth S Hughes, Udai S Kammula, Richard E Royal, Richard M Sherry, John R Wunderlich,[...]. Blood 2009
Laura A Johnson, Richard A Morgan, Mark E Dudley, Lydie Cassard, James C Yang, Marybeth S Hughes, Udai S Kammula, Richard E Royal, Richard M Sherry, John R Wunderlich,[...]. Blood 2009
18
NK cells specifically TCR-dressed to kill cancer cells.
Nadia Mensali, Pierre Dillard, Michael Hebeisen, Susanne Lorenz, Theodossis Theodossiou, Marit Renée Myhre, Anne Fåne, Gustav Gaudernack, Gunnar Kvalheim, June Helen Myklebust,[...]. EBioMedicine 2019
Nadia Mensali, Pierre Dillard, Michael Hebeisen, Susanne Lorenz, Theodossis Theodossiou, Marit Renée Myhre, Anne Fåne, Gustav Gaudernack, Gunnar Kvalheim, June Helen Myklebust,[...]. EBioMedicine 2019
18
18
CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
18
Biotechnologies to tackle the challenge of neoantigen identification.
Marion Arnaud, Margaux Duchamp, Sara Bobisse, Philippe Renaud, George Coukos, Alexandre Harari. Curr Opin Biotechnol 2020
Marion Arnaud, Margaux Duchamp, Sara Bobisse, Philippe Renaud, George Coukos, Alexandre Harari. Curr Opin Biotechnol 2020
18
An immunogenic personal neoantigen vaccine for patients with melanoma.
Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter,[...]. Nature 2017
Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter,[...]. Nature 2017
18
Acquired T-Cell Immunodeficiency in Thymoma Patients.
Petros Christopoulos, Paul Fisch. Crit Rev Immunol 2016
Petros Christopoulos, Paul Fisch. Crit Rev Immunol 2016
18
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients.
Ronny Ben-Avi, Ronit Farhi, Alon Ben-Nun, Marina Gorodner, Eyal Greenberg, Gal Markel, Jacob Schachter, Orit Itzhaki, Michal J Besser. Cancer Immunol Immunother 2018
Ronny Ben-Avi, Ronit Farhi, Alon Ben-Nun, Marina Gorodner, Eyal Greenberg, Gal Markel, Jacob Schachter, Orit Itzhaki, Michal J Besser. Cancer Immunol Immunother 2018
18
Tumor Antigen Escape from CAR T-cell Therapy.
Robbie G Majzner, Crystal L Mackall. Cancer Discov 2018
Robbie G Majzner, Crystal L Mackall. Cancer Discov 2018
18
Induction of neoantigen-reactive T cells from healthy donors.
Muhammad Ali, Zsofia Foldvari, Eirini Giannakopoulou, Maxi-Lu Böschen, Erlend Strønen, Weiwen Yang, Mireille Toebes, Benjamin Schubert, Oliver Kohlbacher, Ton N Schumacher,[...]. Nat Protoc 2019
Muhammad Ali, Zsofia Foldvari, Eirini Giannakopoulou, Maxi-Lu Böschen, Erlend Strønen, Weiwen Yang, Mireille Toebes, Benjamin Schubert, Oliver Kohlbacher, Ton N Schumacher,[...]. Nat Protoc 2019
18
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Jamshid Hadjati. Front Immunol 2020
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Jamshid Hadjati. Front Immunol 2020
18
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.
Steven A Rosenberg, James C Yang, Richard M Sherry, Udai S Kammula, Marybeth S Hughes, Giao Q Phan, Deborah E Citrin, Nicholas P Restifo, Paul F Robbins, John R Wunderlich,[...]. Clin Cancer Res 2011
Steven A Rosenberg, James C Yang, Richard M Sherry, Udai S Kammula, Marybeth S Hughes, Giao Q Phan, Deborah E Citrin, Nicholas P Restifo, Paul F Robbins, John R Wunderlich,[...]. Clin Cancer Res 2011
18
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma.
Kendra C Foley, Michael I Nishimura, Tamson V Moore. Melanoma Res 2018
Kendra C Foley, Michael I Nishimura, Tamson V Moore. Melanoma Res 2018
18
Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor.
Edmund K Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S Wang, Veena Kapoor, Jarrod Predina, Daniel J Powell, James L Riley, Carl H June, Steven M Albelda. Clin Cancer Res 2011
Edmund K Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S Wang, Veena Kapoor, Jarrod Predina, Daniel J Powell, James L Riley, Carl H June, Steven M Albelda. Clin Cancer Res 2011
18
A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression.
Petros Christopoulos, Elaine P Dopfer, Miroslav Malkovsky, Philipp R Esser, Hans-Eckart Schaefer, Alexander Marx, Sylvia Kock, Nicole Rupp, Myriam R Lorenz, Klaus Schwarz,[...]. J Immunol 2015
Petros Christopoulos, Elaine P Dopfer, Miroslav Malkovsky, Philipp R Esser, Hans-Eckart Schaefer, Alexander Marx, Sylvia Kock, Nicole Rupp, Myriam R Lorenz, Klaus Schwarz,[...]. J Immunol 2015
18
Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors.
Daniel T Harris, David M Kranz. Trends Pharmacol Sci 2016
Daniel T Harris, David M Kranz. Trends Pharmacol Sci 2016
18
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
Edward B Garon, Matthew D Hellmann, Naiyer A Rizvi, Enric Carcereny, Natasha B Leighl, Myung-Ju Ahn, Joseph Paul Eder, Ani S Balmanoukian, Charu Aggarwal, Leora Horn,[...]. J Clin Oncol 2019
Edward B Garon, Matthew D Hellmann, Naiyer A Rizvi, Enric Carcereny, Natasha B Leighl, Myung-Ju Ahn, Joseph Paul Eder, Ani S Balmanoukian, Charu Aggarwal, Leora Horn,[...]. J Clin Oncol 2019
18
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
18
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar, Simon J Ogrodnik, Florian Janke, Chiara Dalle Fratte, Tomasz Zemojtel,[...]. EBioMedicine 2020
Steffen Dietz, Petros Christopoulos, Zhao Yuan, Arlou Kristina Angeles, Lisa Gu, Anna-Lena Volckmar, Simon J Ogrodnik, Florian Janke, Chiara Dalle Fratte, Tomasz Zemojtel,[...]. EBioMedicine 2020
18
Emerging Roles of ALK in Immunity and Insights for Immunotherapy.
Lan Wang, Vivian Wai Yan Lui. Cancers (Basel) 2020
Lan Wang, Vivian Wai Yan Lui. Cancers (Basel) 2020
25
ALK inhibitors and checkpoint blockade: a cautionary tale of mixing oil with water?
Malini Patel, Salma K Jabbour, Jyoti Malhotra. J Thorac Dis 2018
Malini Patel, Salma K Jabbour, Jyoti Malhotra. J Thorac Dis 2018
28
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
J Mazieres, A Drilon, A Lusque, L Mhanna, A B Cortot, L Mezquita, A A Thai, C Mascaux, S Couraud, R Veillon,[...]. Ann Oncol 2019
18
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Mark A Socinski, Robert M Jotte, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi,[...]. N Engl J Med 2018
Mark A Socinski, Robert M Jotte, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi,[...]. N Engl J Med 2018
18
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.
Yangyang Xu, Bing Wan, Xi Chen, Ping Zhan, Yuan Zhao, Tianli Zhang, Hongbing Liu, Muhammad Zubair Afzal, Said Dermime, Steven N Hochwald,[...]. Transl Lung Cancer Res 2019
Yangyang Xu, Bing Wan, Xi Chen, Ping Zhan, Yuan Zhao, Tianli Zhang, Hongbing Liu, Muhammad Zubair Afzal, Said Dermime, Steven N Hochwald,[...]. Transl Lung Cancer Res 2019
18
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
18
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
18
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
18
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
18
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression.
Markus Chmielewski, Caroline Kopecky, Andreas A Hombach, Hinrich Abken. Cancer Res 2011
Markus Chmielewski, Caroline Kopecky, Andreas A Hombach, Hinrich Abken. Cancer Res 2011
18
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
Marco L Davila, Isabelle Riviere, Xiuyan Wang, Shirley Bartido, Jae Park, Kevin Curran, Stephen S Chung, Jolanta Stefanski, Oriana Borquez-Ojeda, Malgorzata Olszewska,[...]. Sci Transl Med 2014
18
Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
18
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.